scholarly journals STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD® ) Device, in Healthy Adult Subjects

2019 ◽  
Vol 59 (3) ◽  
pp. 394-409 ◽  
Author(s):  
Stephen B. Shrewsbury ◽  
Maria Jeleva ◽  
Kelsey H. Satterly ◽  
Jason Lickliter ◽  
John Hoekman
Author(s):  
Jesús Cebrecos ◽  
James D. Carlson ◽  
Gregorio Encina ◽  
Mounia Lahjou ◽  
Artur Sans ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document